Trinity Biotech plc (TRIB) Ownership

$1.02

north_east
$0.07 (7.37%)
Day's range
$0.9
Day's range
$1.04

Trinity Biotech plc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC 01/31/2024 1.63 M $700,000   -6.15% 4.24%
STONEHILL CAPITAL MANAGEMENT LLC 02/14/2024 1.51 M $649,000   0.00% 3.95%
RENAISSANCE TECHNOLOGIES LLC 02/13/2024 1.35 M $581,000   -0.68% 3.53%
ACADIAN ASSET MANAGEMENT LLC 02/13/2024 684,882 $292,000   -5.34% 1.79%
WHITEFORT CAPITAL MANAGEMENT, LP 02/14/2024 409,517 $175,683   0.00% 1.07%
CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC. 02/09/2024 111,400 $48,000   0.00% 0.29%
BECKER CAPITAL MANAGEMENT INC 02/14/2024 90,000 $38,610   100.00% 0.23%
CITADEL ADVISORS LLC 02/14/2024 32,513 $13,948   100.00% 0.08%
WEALTHSOURCE PARTNERS, LLC 01/16/2024 30,200 $12,956   0.00% 0.08%
ARISTIDES CAPITAL LLC 02/13/2024 28,057 $12,036   -82.71% 0.07%
STATE OF NEW JERSEY COMMON PENSION FUND D 02/02/2024 27,062 $11,610   0.00% 0.07%
CI PRIVATE WEALTH, LLC 02/09/2024 22,035 $9,453   100.00% 0.06%
TWO SIGMA SECURITIES, LLC 02/14/2024 19,037 $8,167   100.00% 0.05%
MILLENNIUM MANAGEMENT LLC 02/14/2024 15,466 $6,635   100.00% 0.04%
MORGAN STANLEY 08/16/2024 14,552 $6,243   0.00% 0.04%
REDWOOD WEALTH MANAGEMENT GROUP, LLC 01/25/2024 14,150 $6,070   -15.02% 0.04%
DYNAMIC ADVISOR SOLUTIONS LLC 01/10/2024 10,000 $5,300   0.00% 0.03%
WILLIAMS & NOVAK, LLC 01/26/2024 10,000 $4,290   100.00% 0.03%
RHUMBLINE ADVISERS 02/08/2024 1,860 $797   0.00% 0.00%
CGC FINANCIAL SERVICES, LLC 01/12/2024 1,500 $644   0.00% 0.00%
BANK OF AMERICA CORP /DE/ 02/14/2024 1,204 $516   0.00% 0.00%
CITADEL ADVISORS LLC 02/14/2024 1,000 $429   100.00% 0.00%
US BANCORP \DE\ 02/09/2024 972 $417   0.00% 0.00%
ATWOOD & PALMER INC 01/12/2024 100 $43   0.00% 0.00%
UBS GROUP AG 02/09/2024 17 $7   -88.03% 0.00%
CITIGROUP INC 02/09/2024 4 $2   0.00% 0.00%
GROUP ONE TRADING, L.P. 02/14/2024 0 $0   -100.00% 0.00%

Trinity Biotech plc institutional Ownership - FAQ's

During the previous two years, 19 institutional investors and hedge funds held shares of Trinity Biotech plc. The most heavily invested institutionals were:

WEALTHSOURCE PARTNERS, LLC: 30,200

Benchmark Capital Advisors: 17,000

Delpha Capital Management, LLC: 0

GOLDMAN CAPITAL MANAGEMENT INC: 46,000

Virtu KCG Holdings LLC: 13,490

JANUS HENDERSON INVESTORS US LLC: 1.42 M

15.70% of Trinity Biotech plc stock is owned by institutional investors.

Institutional investors have bought a total of 3.36 M shares in the last 24 months. This purchase volume represents approximately $3.43 M in transactions.